PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
01-Sep-2021 ExeVir Announces First Patient Enrolled in Phase 1b/2 Clinical Study evaluating XVR011 as antiviral treatment of patients hospitalised for COVID-19 ExeVir
31-Aug-2021 AlzeCure’s Alzheimer’s project receives approval to start next clinical phase I study with ACD856 AlzeCure Pharma AB
27-Aug-2021 Grupo NotreDame Intermédica (GNDI) of Brazil enhances patient care and improves patient access to leading-edge medications by joining Clinerion’s global network of hospital partners on Patient Network Explorer. Clinerion Ltd.
24-Aug-2021 AWAKN LIFE SCIENCES INITIATES THE FIRST KETAMINE TREATMENT STUDY FOR GAMBLING ADDICTION LED BY PROFESSOR CELIA MORGAN Awakn Life Sciences Corp.
24-Aug-2021 BridgeHead Enables Biomedical Imaging Centre’s Enterprise Imaging Strategy For Leading Research BridgeHead Software
23-Aug-2021 Targeting the Putamen with Gene Therapy Leads to Sustained Improvements in Motor and Non-Motor Functions in Children with AADC Deficiency PTC Therapeutics, Inc.
20-Aug-2021 Clinerion patent for technology underpinning Patient Network Explorer is published. Clinerion Ltd.
20-Aug-2021 Human Bone Marrow-derived Mononuclear Cells and Their Applications AcceGen
19-Aug-2021 Antimicrobial Susceptibility Testing Market Growth And Business Intelligence MarketsandMarkets
17-Aug-2021 Cidara Therapeutics and Mundipharma Announce Completion of Enrollment in the Phase 3 ReSTORE Trial of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis Mundipharma
17-Aug-2021 Corvus Pharmaceuticals Announces IND Acceptance for Phase 1/1b Clinical Trial of CPI-818 in China Corvus Pharmaceuticals
13-Aug-2021 Velocity Clinical Research strengthens management team amid European expansion Velocity Clinical Research
12-Aug-2021 Biotium launches optimized solution for exosome detection by flow cytometry Biotium
12-Aug-2021 MeiraGTx Reports Second Quarter 2021 Financial and Operational Results MeiraGTx Holdings plc
11-Aug-2021 PONVORY®▼ (ponesimod), a Once Daily, Oral Therapy Authorised in Great Britain for the Treatment of Adults with Relapsing Forms of Multiple Sclerosis (RMS) with Active Disease Defined by Clinical or Imaging Features Janssen
11-Aug-2021 Amplity’s Blended Engagement Model: A New Post-COVID Health Care Provider (HCP) Customer Engagement Model for Pharma Amplity Health
11-Aug-2021 PHS Health Solutions Unveils Company Rebrand to Amplity Health Amplity Health
11-Aug-2021 Amplity Health Acquires RealHealthData Amplity Health
11-Aug-2021 Amplity Health’s Remote Engagement Center Is Named J.D. Power Certified Amplity Health’s
11-Aug-2021 SCYNEXIS and Amplity Health Announce Agreement to Support the Anticipated U.S. Commercialization of BrexafemmeTM (Ibrexafungerp) for Vaginal Yeast Infections Amplity Health